Compositions and methods for topical diagnostic and therapeutic transport

Details for Australian Patent Application No. 2005251676 (hide)

Owner Revance Therapeutics, Inc.

Inventors Waugh, Jacob M.; Dake, Michael D.

Agent Spruson & Ferguson

Pub. Number AU-B-2005251676

PCT Pub. Number WO2005/120546

Priority 60/550,014 03.03.04 US

Filing date 3 March 2005

Wipo publication date 22 December 2005

Acceptance publication date 29 September 2011

International Classifications

A01N 25/34 (2006.01) Biocides - Shaped forms, e.g. sheets, not provided for in any other group of this main group

A61K 9/38 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/74 (2006.01) - Synthetic polymeric materials

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61K 39/21 (2006.01) Medicinal preparations containing antigens or antibodies - Retroviridae, e.g. equine infectious anemia virus

A61K 47/32 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

C07K 17/00 (2006.01) Carrier-bound or immobilised peptides

Event Publications

5 October 2006 PCT application entered the National Phase

  PCT publication WO2005/120546 Priority application(s): WO2005/120546

6 September 2007 Change of Name(s) of Applicant(s), Section 104

  Essentia Biosystems, Inc. The name of the applicant has been changed to Revance Therapeutics, Inc.

29 September 2011 Application Accepted

  Published as AU-B-2005251676

2 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005251677-Antimicrobial tissue products with reduced skin irritation potential

2005251673-Use of lactic acid bacteria for decreasing gum bleeding and reducing oral inflammation